Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation

Mostrar otras versiones (2)

Vaccine-induced neutralizing antibodies (nAbs) are key biomarkers considered to be associated with vaccine efficacy. In United States Government-sponsored phase 3 efficacy trials of COVID-19 vaccines, nAbs are measured by two different validated pseudovirus-based SARS-CoV-2 neutralization assays, wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yunda, Borisov, Oleg, Kee, Jia Jin, Carpp, Lindsay N., Wrin, Terri, Cai, Suqin, Sarzotti-Kelsoe, Marcella, McDanal, Charlene, Eaton, Amanda, Pajon, Rolando, Hural, John, Posavad, Christine M., Gill, Katherine, Karuna, Shelly, Corey, Lawrence, McElrath, M. Juliana, Gilbert, Peter B., Petropoulos, Christos J., Montefiori, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423224/
https://www.ncbi.nlm.nih.gov/pubmed/34494017
http://dx.doi.org/10.21203/rs.3.rs-862572/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423224/
https://www.ncbi.nlm.nih.gov/pubmed/34494017
http://dx.doi.org/10.21203/rs.3.rs-862572/v1

Ejemplares similares